124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study

NCT01583842 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Funding

Conditions

Neuroblastoma

Interventions

DRUG: 124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)
DRUG: 124I-MIBG (carrier added)
PROCEDURE: Positron Emission Tomography (PET) /Computerized tomography (CT)

Sponsor

Miguel Pampaloni

Collaborators

[object Object]
[object Object]